MediciNova

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MediciNova and other ETFs, options, and stocks.

About MNOV

MediciNova, Inc. is a biopharmaceutical company, which focuses on developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus. Its programs include MN-001, MN-166 neurology diseases, and MN-221 respiratory diseases.

CEO

Yuichi Iwaki

CEOYuichi Iwaki

Employees

Employees13

Headquarters

La Jolla, California

HeadquartersLa Jolla, California

Founded

2000

Founded2000

Employees

Employees13

MNOV Key Statistics

Market cap

76.51M

Market cap76.51M

Price-Earnings ratio

-6.92

Price-Earnings ratio-6.92

Dividend yield

—

Dividend yield—

Average volume

12.12K

Average volume12.12K

High today

$1.56

High today$1.56

Low today

$1.49

Low today$1.49

Open price

$1.55

Open price$1.55

Volume

4.67K

Volume4.67K

52 Week high

$2.55

52 Week high$2.55

52 Week low

$1.12

52 Week low$1.12

MediciNova

Why Robinhood?

MediciNova, Inc. is a biopharmaceutical company, which focuses on developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus. Its programs include MN-001, MN-166 neurology diseases, and MN-221 respiratory diseases. Show more

MNOV Key Statistics

MediciNova, Inc. is a biopharmaceutical company, which focuses on developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus. Its programs include MN-001, MN-166 neurology diseases, and MN-221 respiratory diseases.